|
|
|
Insider
Information: |
Mehra Anand |
Relationship: |
Director |
City: |
Menlo Park |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
11 |
|
Direct
Shares |
11,769,795 |
|
Indirect Shares
|
6,925,513 |
|
|
Direct
Value |
$208,767,505 |
|
|
Indirect Value
|
$114,026,792 |
|
|
Total
Shares |
18,695,308 |
|
|
Total
Value |
$322,794,297 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Aerie Pharmaceuticals Inc |
AERI |
Director |
2015-04-10 |
1,700 |
2015-04-15 |
469,591 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2014-09-12 |
40,020 |
2014-09-12 |
506,270 |
Premium* |
|
Ocugen Ord Shs |
OCGN |
10% Owner |
2014-12-08 |
0 |
2014-12-08 |
2,077,040 |
Premium* |
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2019-12-17 |
0 |
Premium* |
|
aTyr Pharma Inc |
LIFE |
10% Owner |
2015-05-12 |
1,866,126 |
2015-05-12 |
0 |
Premium* |
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-06 |
2,974,811 |
2015-10-05 |
0 |
Premium* |
|
Aclaris Therapeutics, Inc. |
ACRS |
Director |
2023-06-02 |
38,704 |
2018-10-22 |
1,911,573 |
Premium* |
|
Iterum Therapeutics Plc |
ITRM |
10% Owner |
2018-05-30 |
1,726,514 |
2018-05-30 |
0 |
Premium* |
|
Principia Biopharma Inc |
PRNB |
10% Owner |
2018-09-18 |
2,038,208 |
2018-09-18 |
0 |
Premium* |
|
Galera Therapeutics, Inc. |
GRTX |
10% Owner |
2019-11-12 |
3,083,712 |
2019-11-12 |
0 |
Premium* |
|
Merus Nv |
MRUS |
Director |
|
0 |
2020-01-01 |
1,961,039 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ITRM |
Iterum Therapeutics Plc |
10% Owner |
|
2018-05-30 |
4 |
B |
$13.00 |
$6,500,000 |
D/D |
500,000 |
1,726,514 |
2.45 |
- |
|
MRUS |
Merus Nv |
Director |
|
2020-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,961,039 |
|
% |
|
OCGN |
Ocugen Ord Shs |
10% Owner |
|
2014-12-08 |
4 |
A |
$0.00 |
$0 |
I/I |
1,572,083 |
1,572,083 |
0 |
- |
|
OCGN |
Ocugen Ord Shs |
10% Owner |
|
2014-12-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(8,808) |
2,077,040 |
0 |
- |
|
OCGN |
Ocugen Ord Shs |
10% Owner |
|
2014-12-08 |
4 |
B |
$11.00 |
$5,502,178 |
I/I |
500,198 |
2,085,848 |
1.5 |
- |
|
OCGN |
Ocugen Ord Shs |
10% Owner |
|
2014-12-08 |
4 |
S |
$11.00 |
$11,022 |
I/I |
(1,002) |
1,585,650 |
0 |
- |
|
OCGN |
Ocugen Ord Shs |
10% Owner |
|
2014-12-08 |
4 |
OE |
$0.76 |
$11,072 |
I/I |
14,569 |
1,586,652 |
0 |
- |
|
PRNB |
Principia Biopharma Inc |
10% Owner |
|
2018-09-18 |
4 |
B |
$17.00 |
$4,590,000 |
D/D |
270,000 |
2,038,208 |
2.45 |
- |
|
PRNB |
Principia Biopharma Inc |
10% Owner |
|
2018-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,768,208 |
1,768,208 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2015-02-04 |
4 |
B |
$23.00 |
$5,175,000 |
I/I |
225,000 |
2,118,576 |
2.1 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2015-02-04 |
4 |
A |
$0.00 |
$0 |
I/I |
1,893,576 |
1,893,576 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2015-10-07 |
4 |
S |
$45.56 |
$11,600,801 |
I/I |
(251,912) |
1,866,664 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2015-10-08 |
4 |
S |
$44.38 |
$12,473,634 |
I/I |
(277,632) |
1,589,032 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2015-11-09 |
4 |
S |
$60.07 |
$1,559,117 |
I/I |
(25,955) |
1,563,077 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2015-11-10 |
4 |
S |
$60.01 |
$355,979 |
I/I |
(5,932) |
1,557,145 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2015-11-11 |
4 |
S |
$60.13 |
$5,871,334 |
I/I |
(97,644) |
1,459,501 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2015-11-12 |
4 |
S |
$60.00 |
$64,440 |
I/I |
(1,074) |
1,458,427 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2015-11-25 |
4 |
S |
$60.01 |
$1,056,836 |
I/I |
(17,611) |
1,440,816 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2015-11-27 |
4 |
S |
$60.02 |
$321,107 |
I/I |
(5,350) |
1,435,466 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2016-05-31 |
4 |
AS |
$60.00 |
$30,000 |
I/I |
(500) |
1,434,966 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2016-08-01 |
4 |
AS |
$60.03 |
$1,360,580 |
I/I |
(22,665) |
1,412,301 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2016-08-03 |
4 |
AS |
$60.00 |
$276,720 |
I/I |
(4,612) |
1,407,689 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2016-08-04 |
4 |
AS |
$60.00 |
$27,120 |
I/I |
(452) |
1,407,237 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2016-08-08 |
4 |
AS |
$60.47 |
$6,047 |
I/I |
(100) |
1,407,137 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2016-08-10 |
4 |
AS |
$60.02 |
$414,138 |
I/I |
(6,900) |
1,400,237 |
0 |
- |
|
78 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|